Status:
COMPLETED
Improving Adherence to Controller Medication in Children With Asthma
Lead Sponsor:
St. Justine's Hospital
Conditions:
Asthma in Children
Adherence, Medication
Eligibility:
All Genders
2-17 years
Brief Summary
Asthma is a common pediatric condition that can be well controlled with regular use of controller medications, however adherence to these is low, resulting in preventable exacerbations and important s...
Detailed Description
Background: Asthma affects one in ten children and is among the most common causes of emergency department (ED) visits and hospitalization in paediatrics. Regular use of asthma controller medications ...
Eligibility Criteria
Inclusion
- (1) child with documented prescription for a controller medication at recruitment visit: inhaled corticosteroids ± Long-acting beta agonists (LABA) and/or Leukotriene receptor antagonists (LTRA)
- (2) consent to reMED database (medication data registry)
Exclusion
- (1) Child with other chronic pulmonary disease (e.g., cystic fibrosis) that could influence asthma control,
- (2) parents' insufficient knowledge of French or English to complete questionnaires either alone or with support from a research assistant.
Key Trial Info
Start Date :
August 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 18 2025
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT05278000
Start Date
August 25 2022
End Date
July 18 2025
Last Update
July 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asthma Clinic of the CHU Sainte-Justine
Montreal, Quebec, Canada, H3T 1C5